🇺🇸 FDA
Patent

US 9114102

Method of inhibiting ABCG2 and related treatments

granted A61KA61K31/015A61K31/28

Quick answer

US patent 9114102 (Method of inhibiting ABCG2 and related treatments) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/015, A61K31/28, A61K31/4155, A61K31/439